Skip to content

Inferior Submucosal Turbinectomy Versus Blunt Turbinectomy for Inferior Turbinate Hypertrophy

to Compare Two Well Popularized Methods of Inferior Nasal Turbinectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00651092
Enrollment
50
Registered
2008-04-02
Start date
2008-03-31
Completion date
2010-01-31
Last updated
2008-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilateral Inferior Turbinates Hypertrophy

Keywords

turbinectomy

Brief summary

The aim of the study is to compare endoscopic submucosal inferior turbinectomy to blunt turbinectomy in terms of subjective and objective parameters.

Detailed description

The two methods of nasal inferior turbinectomy are well popularized and in use for long periods of time. Endoscopic submucosal inferior turbinectomy is performed in our hospital and blunt turbinectomy is performed usually in privat clinics outside the hospital where there is no endoscopic equipment. We will examine both subjective (QOL questionaire) and objective parameters(rhinomanometry- a non invasive method to evaluate nasal airflow, saccharine test, nasal endoscopy) in our comparison of the outcome of these two methods.

Interventions

PROCEDUREbilateral nasal inferior turbinectomy

the operation is performed endonasally under general or local anesthesia, the inferior turbinates are resected and removed

PROCEDUREendoscopic submucosal resection of the inferior turbinates

surgery of the inferior turbinates- endonasally with endoscopic instruments and by performing submucosal resection of the nasal turbinates

Sponsors

Soroka University Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* all patients above 18 years

Exclusion criteria

* can not answer a written questionaire

Design outcomes

Primary

MeasureTime frame
quality of life1 year

Secondary

MeasureTime frame
rhinomanometry, saccharine test, nasal endoscopy1 year

Contacts

Primary Contactnili segal, md
segalna@012.net.il+972544268202
Backup Contactmoshe puterman, md
puterman@netvision.net.il+97286400521

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026